Back

Ready for prime time as first-line therapy ? CONTRA.

30 April 2017 (16:50 - 17:00)
Organised by:
Congress Presentation Part of: The Grand Debate 1: Neprilysin inhibitor - Vasodilators - LCZ 696 (Sacubitril/Valsartan) Diuretics HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Professor Mariell Jessup

American Heart Association, Dallas (United States of America)

5 More presentations in this session

Presentation thumbnail
Professor E. Braunwald (Boston, US)
Slides Video
Presentation thumbnail
Professor J. McMurray (Glasgow, GB)
Slides Video
Presentation thumbnail
Video
Presentation thumbnail
Video
Presentation thumbnail
Slides Video

Access the full session

Session thumbnail
The Grand Debate 1: Neprilysin inhibitor - Vasodilators - LCZ 696 (Sacubitril/Valsartan)

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

30 April 2017 16:50 CET
You may be interested in
thumbnail
Congress Session
Challenges in hypertension management
26 August 2023
thumbnail
Congress Presentation
Flecainide efficacy in outflow tract vs non-outflow tract premature ventricular contractions: A subanalysis of the UNIFLECA study
13 April 2026
thumbnail
Congress Presentation
Discussant review - COP-AF
25 August 2023
thumbnail
Congress Presentation
Clopidogrel in-laboratory versus outpatient preloading in chronic coronary syndrome patients undergoing diagnostic coronary angiography with potential ad-hoc percutaneous coronary intervention
31 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources